5-Cyclopropyl-1,3,4-oxadiazol-2-amine Building Blocks
KPL024113
Produced by Kishida Chemical Co., Ltd.
250 mg. net
5-(Pyridin-4-yl)-1,3,4-oxadiazol-2-amine Building Blocks
KPL024121
100 mg. net
KPL024123
5-(2-Methoxyphenyl)-1,3,4-oxadiazol-2-amine Building Blocks
KPL024131
KPL024133
3-(5-tert-Butyl-1,3,4-oxadiazol-2-yl)piperidine Building Blocks
KPL024141
KPL024143
2-(5-tert-Butyl-1,3,4-oxadiazol-2-yl)piperidine Building Blocks
KPL024151
KPL024153
2-(5-Cyclobutyl-1,3,4-oxadiazol-2-yl)piperidine Building Blocks
KPL024161
KPL024163
3,3-Difluorocyclohexanecarboxylicacid Building Blocks
KPL024171
KPL024173
(3,3-Difluorocyclopentyl)methanaminehydrochloride Building Blocks
KPL024181
KPL024183
(3,3-Difluorocyclohexyl)methanaminehydrochloride Building Blocks
KPL024191
KPL024193
(3,3-Dimethylcyclopentyl)methanaminehydrochloride Building Blocks
KPL024201
KPL024203
tert-Butyl4-(hydroxymethyl)piperidin-4-ylcarbamate Building Blocks
KPL024211
KPL024213
tert-Butyl3-(hydroxymethyl)azetidin-3-ylcarbamate Building Blocks
KPL024221
KPL024223
N2-(2-Methoxyphenyl)pyrimidine-2,5-diamine Building Blocks
KPL024231
KPL024233
N2-(4-Methoxyphenyl)pyrimidine-2,5-diamine Building Blocks
KPL024241
KPL024243
N2-[4-(Trifluoromethyl)phenyl]pyrimidine-2,5-diamine Building Blocks
KPL024251
KPL024253
4-(2-Oxoazepan-1-yl)benzoic acid Building Blocks
KPL024261
11311–11340 of 29439 results
